Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-09-27Clinical Trial Update: Advance Care Planning Impact on the Consistency of Older Adults With Lung Cancer and Their Potential Surrogates Regarding Life-Sustaining Treatment Preferences [NA]
An ongoing clinical trial evaluates whether advance care planning improves the consistency of life-sustaining-treatment preferences between …
-
CLINICAL_TRIALS research · 2024-09-26Clinical Trial Update: Neoajuvant Tislelizumab Combined with Chemotherapy for Initially Unresectable Stage IIIA/N2 Non-small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating neoadjuvant tislelizumab plus chemotherapy for initially unresectable stage IIIA/N2 non-small cell lung cancer is…
-
CLINICAL_TRIALS research · 2024-09-25Clinical Trial Update: Efficacy and Safety of Intratumoral Toluenesulfonamide (PTS) Injection in Stage IV Driver Gene-Negative NSCLC With/Without Chemoimmunotherapy [Phase 3]
Phase 3 trial evaluating intratumoral toluenesulfonamide (PTS) for stage IV driver gene-negative non-small cell lung cancer, with or without…
-
CLINICAL_TRIALS research · 2024-09-25Clinical Trial Update: AB122 Platform Study [Phase 1]
Phase 1 AB122 platform study is currently recruiting for advanced or metastatic solid tumors, including pancreatic ductal adenocarcinoma and…
-
CLINICAL_TRIALS research · 2024-09-25Clinical Trial Update: Association Between Microbiome and the Efficacy and Safety of PD-1/PD-L1 Blockade in Resectable NSCLC
A clinical trial investigating whether the gut microbiome influences the efficacy and safety of PD-1/PD-L1 blockade in patients with resecta…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-09-25Clinical Trial Update: Lifei Xiaoji Wan in Treatment of Advanced NSCLC [NA]
Clinical trial update for Lifei Xiaoji Wan in treating advanced non-small cell lung cancer; recruiting.
-
CLINICAL_TRIALS research · 2024-09-23Clinical Trial Update: MONDRIAN: Multi-omics Integrative Modelling for Stereotactic Body Radiotherapy in Early-stage Non-small Cell Lung Cancer
MONDRIAN is a clinical trial investigating a multi-omics integrative modelling approach to guide stereotactic body radiotherapy in early-sta…
-
CLINICAL_TRIALS research · 2024-09-23Clinical Trial Update: Sequential Chemo-immunotherapy Plus Thoracic Radiotherapy for Elderly And/or Frail Stage III Non-small-cell Lung Cancer [NA]
A clinical trial evaluating sequential chemo-immunotherapy followed by thoracic radiotherapy for elderly and/or frail patients with stage II…
-
CLINICAL_TRIALS research · 2024-09-23Clinical Trial Update: Neoadjuvant With Tα1 Plus Immuno-chemotherapy for Resectable NSCLC [NA]
This clinical trial update describes a neoadjuvant study combining thymosin alpha-1 with immuno-chemotherapy for resectable non-small cell l…
-
CLINICAL_TRIALS research · 2024-09-20Clinical Trial Update: Intrathecal Pemetrexed Combined With High-dose Furmonertinib and Beva for EGFR-m NSCLC With Leptomeningeal Metastases [Phase 2]
A Phase 2 trial update describing a novel combination of intrathecal pemetrexed with high-dose furmonertinib and bevacizumab for EGFR-mutant…
-
CLINICAL_TRIALS research · 2024-09-20Clinical Trial Update: ALK Tyrosine Kinase Inhibitors in ALK-rearranged Advanced Squamous Cell Carcinoma [Phase 2]
This clinical trial is evaluating ALK tyrosine kinase inhibitors in ALK-rearranged advanced squamous cell carcinoma (a form of non-small cel…
-
CLINICAL_TRIALS research · 2024-09-20Clinical Trial Update: Sunvozertinib Plus Anlotinib as 1L Treatment in EGFR Mutant Advanced NSCLC-RW [Phase 2]
A Phase 2 clinical trial is investigating Sunvozertinib in combination with Anlotinib as first-line treatment for EGFR-mutant advanced non-s…
-
CLINICAL_TRIALS research · 2024-09-20Clinical Trial Update: A Study With Central Nervous System Metastatic EGFR Mutation Positive Non-small Cell Lung Cancer
A clinical trial update describing a study of EGFR mutation-positive non-small cell lung cancer with central nervous system metastases. The …
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Immuno-effect of Tα1 for Stage I NSCLC [NA]
A clinical trial update noting ongoing recruitment for a study examining the immune effects of thymosin alpha-1 in Stage I non-small cell lu…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: A Retrospective Study: Evaluation of the Efficacy of Immunotherapy With Rare Mutations in Non-small Cell Lung Cancer
This document describes a retrospective study evaluating the efficacy of immunotherapy in non-small cell lung cancer patients with rare muta…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Reinforced and Non-Reinforced Staple Lines in Fissureless Lobectomy [Phase 1]
A Phase 1 clinical trial evaluating reinforced versus non-reinforced staple lines in fissureless lobectomy for lung cancer, currently not re…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Bronchoscopic Cryoablation Combined With Chemo-Immunotherapy in NSCLC With Central Airway Obstruction [Phase 2]
This is an ongoing Phase 2 clinical trial investigating bronchoscopic cryoablation combined with chemotherapy and immunotherapy in patients …
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: The Patient-Reported Outcomes in ALK Positive Advanced NSCLC in China
This clinical trial update reports a study in China evaluating patient-reported outcomes in ALK-positive advanced non-small cell lung cancer…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: PD-1 Combined With Pyrotinib for Chemotherapy Failure HER2 Insertion Mutation Advanced NSCLC [Phase 2]
Phase 2 trial evaluating a PD-1 inhibitor in combination with Pyrotinib for chemotherapy-refractory non-small cell lung cancer with HER2 ins…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Sunvozertinib Plus Anlotinib as 1L Treatment in EGFR-Sensitive Mutations Combined With Co-Mutations Advanced NSCLC [Phase 2]
A Phase 2 trial evaluating Sunvozertinib plus Anlotinib as first-line therapy for EGFR-sensitizing mutations with co-mutations in advanced n…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: High-dose Furmonertinib for First-line Treatment of EGFR Mutated NSCLC With Central Nervous System (CNS) Metastases [Phase 2]
This update describes a Phase 2 trial evaluating high-dose furmonertinib as first-line treatment for EGFR-mutated non-small cell lung cancer…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: A Real-World Study of Treatment Patterns and Effectiveness in MET Mutation-Positive Advanced Lung Cancer
A real-world study protocol evaluating treatment patterns and effectiveness in MET mutation-positive advanced lung cancer, currently recruit…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Phase II Clinical Trial to Evaluate the Safety and Efficacy of TQB2450 Injection Combined With Anlotinib Capsule and Chemotherapy in the Treatment of Immunoresistant Advanced Non-small Cell Lung Cancer [Phase 2]
Phase II clinical trial evaluating TQB2450 in combination with Anlotinib capsule and chemotherapy for immunoresistant advanced non-small cel…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: A Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Participants with KRAS G12C Mutation Advanced Solid Tumors [Phase 1]
A Phase Ib trial evaluating HS-10370 in combination with other anti-cancer therapies for KRAS G12C-mutant advanced solid tumors, including n…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Induction Therapy With Serplulimab Combined With Chemotherapy for Unresectable Stage III Non-small Cell Lung Cancer
This document reports a clinical trial evaluating induction therapy with Serplulimab plus chemotherapy for unresectable stage III non-small …